688 related articles for article (PubMed ID: 17996566)
1. Clinical factors, but not C-reactive protein, predict progression of calcific aortic-valve disease: the Cardiovascular Health Study.
Novaro GM; Katz R; Aviles RJ; Gottdiener JS; Cushman M; Psaty BM; Otto CM; Griffin BP
J Am Coll Cardiol; 2007 Nov; 50(20):1992-8. PubMed ID: 17996566
[TBL] [Abstract][Full Text] [Related]
2. Relations of inflammation and novel risk factors to valvular calcification.
Fox CS; Guo CY; Larson MG; Vasan RS; Parise H; O'Donnell CJ; D'Agostino RB; Keaney JF; Benjamin EJ
Am J Cardiol; 2006 May; 97(10):1502-5. PubMed ID: 16679093
[TBL] [Abstract][Full Text] [Related]
3. Plasma homocysteine and calcific aortic valve disease.
Novaro GM; Aronow HD; Mayer-Sabik E; Griffin BP
Heart; 2004 Jul; 90(7):802-3. PubMed ID: 15201256
[No Abstract] [Full Text] [Related]
4. Serum gamma-glutamyltransferase activity is increased in patients with calcific aortic valve stenosis.
Bozbas H; Yildirir A; Demir O; Cakmak A; Karacaglar E; Yilmaz M; Eroglu S; Pirat B; Ozin B; Muderrisoglu H
J Heart Valve Dis; 2008 Jul; 17(4):371-5. PubMed ID: 18751465
[TBL] [Abstract][Full Text] [Related]
5. Association between circulating oxidised low-density lipoprotein and fibrocalcific remodelling of the aortic valve in aortic stenosis.
Côté C; Pibarot P; Després JP; Mohty D; Cartier A; Arsenault BJ; Couture C; Mathieu P
Heart; 2008 Sep; 94(9):1175-80. PubMed ID: 17932090
[TBL] [Abstract][Full Text] [Related]
6. Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies.
Freeman RV; Otto CM
Circulation; 2005 Jun; 111(24):3316-26. PubMed ID: 15967862
[No Abstract] [Full Text] [Related]
7. Serum C-reactive protein is an independent risk factor predicting cardiometabolic risk.
Onat A; Can G; Hergenç G
Metabolism; 2008 Feb; 57(2):207-14. PubMed ID: 18191050
[TBL] [Abstract][Full Text] [Related]
8. Determinants of occurrence of aortic sclerosis in an aging population.
Ngo DT; Sverdlov AL; Willoughby SR; Nightingale AK; Chirkov YY; McNeil JJ; Horowitz JD
JACC Cardiovasc Imaging; 2009 Aug; 2(8):919-27. PubMed ID: 19679278
[TBL] [Abstract][Full Text] [Related]
9. Correlation of high sensitivity C-reactive protein and calcific aortic valve disease.
Jeevanantham V; Singh N; Izuora K; D'Souza JP; Hsi DH
Mayo Clin Proc; 2007 Feb; 82(2):171-4. PubMed ID: 17290723
[TBL] [Abstract][Full Text] [Related]
10. Effect of statin treatment on aortic valve and coronary artery calcification.
Mohler ER; Wang H; Medenilla E; Scott C
J Heart Valve Dis; 2007 Jul; 16(4):378-86. PubMed ID: 17702362
[TBL] [Abstract][Full Text] [Related]
11. Is it time for a new paradigm in calcific aortic valve disease?
Owens DS; Otto CM
JACC Cardiovasc Imaging; 2009 Aug; 2(8):928-30. PubMed ID: 19679279
[No Abstract] [Full Text] [Related]
12. Systemic and local levels of fetuin-A in calcific aortic valve stenosis.
Kaden JJ; Reinöhl JO; Blesch B; Brueckmann M; Haghi D; Borggrefe M; Schmitz F; Klomfass S; Pillich M; Ortlepp JR
Int J Mol Med; 2007 Aug; 20(2):193-7. PubMed ID: 17611637
[TBL] [Abstract][Full Text] [Related]
13. Progression of aortic valve sclerosis and aortic valve stenosis: what is the role of statin treatment?
Antonini-Canterin F; Popescu BA; Huang G; Korcova-Miertusova R; Rivaben D; Faggiano P; Pavan D; Piazza R; Bolis A; Ciavattone A; Ruggiero A; Nicolosi GL
Ital Heart J; 2005 Feb; 6(2):119-24. PubMed ID: 15819504
[TBL] [Abstract][Full Text] [Related]
14. C-reactive protein and risk of cardiovascular disease in men and women from the Framingham Heart Study.
Wilson PW; Nam BH; Pencina M; D'Agostino RB; Benjamin EJ; O'Donnell CJ
Arch Intern Med; 2005 Nov; 165(21):2473-8. PubMed ID: 16314543
[TBL] [Abstract][Full Text] [Related]
15. [Chlamydia pneumoniae--a new risk factor for calcific aortic stenosis?].
Kaden JJ; Haghi D; Vocke DC; Brueckmann M; Süselbeck T; Borggrefe M
Med Klin (Munich); 2005 Jun; 100(6):334-9. PubMed ID: 15968485
[TBL] [Abstract][Full Text] [Related]
16. Cronic non-rheumatic valvular heart disease. An autopsy study.
Hallgrímsson J
Acta Pathol Microbiol Scand A; 1976 May; 84(3):247-52. PubMed ID: 1274589
[TBL] [Abstract][Full Text] [Related]
17. Calcific aortic valve disease should not be considered as a degenerative disease anymore.
Li YB; Hu CL; Liu J; Tang QZ; Huang CX
Med Hypotheses; 2007; 68(6):1233-5. PubMed ID: 17011715
[TBL] [Abstract][Full Text] [Related]
18. Stage-related effect of statin treatment on the progression of aortic valve sclerosis and stenosis.
Antonini-Canterin F; Hîrşu M; Popescu BA; Leiballi E; Piazza R; Pavan D; Ginghină C; Nicolosi GL
Am J Cardiol; 2008 Sep; 102(6):738-42. PubMed ID: 18773999
[TBL] [Abstract][Full Text] [Related]
19. Natural history of aortic valve disease following intervention for rheumatic mitral valve disease.
Namboodiri N; Remash K; Tharakan JA; Shajeem O; Nair K; Titus T; Ajitkumar VK; Sivasankaran S; Krishnamoorthy KM; Harikrishnan SP; Harikrishnan MS; Bijulal S
J Heart Valve Dis; 2009 Jan; 18(1):61-7. PubMed ID: 19301554
[TBL] [Abstract][Full Text] [Related]
20. Lower serum calcium levels are associated with greater calcium hydroxyapatite deposition in native aortic valves of male patients with severe calcific aortic stenosis.
Ortlepp JR; Pillich M; Schmitz F; Mevissen V; Koos R; Weiss S; Stork L; Dronskowski R; Langebartels G; Autschbach R; Brandenburg V; Woodruff S; Kaden JJ; Hoffmann R
J Heart Valve Dis; 2006 Jul; 15(4):502-8. PubMed ID: 16901043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
